Monday, November 2, 2026

Dyson CameraJet™: The Revolutionary Oral Care Device Combining Brushing and Flossing in One

Dyson introduces the CameraJet™, combining teeth brushing and interdental cleaning for the first time in South Korea.

JLK Partners with Takeyama: What This Means for AI Stroke Solutions in Japan’s Medical Market

JLK, a medical AI company, partners with Takeyama to expand its distribution network in Japan, enhancing local presence.

Hanskin enters 1,400 Ulta Beauty stores in U.S., expanding North American offline presence

Hanskin expands its North American presence by launching "Hyaluron Skin Essence" in 1,400 Ulta Beauty stores, enhancing brand visibility.

Health

Leading Fertility Experts to Gather in Busan as Patients Seek Answers on Treatment Options

International reproductive immunology experts will gather in Busan to discuss the causes and treatment of infertility, with three public forums giving patients and families an opportunity to ask specialists directly about repeated IVF failures, recurrent miscarriages and possible treatment approaches.

Daewoong Pharmaceutical Targets Global Market With Long-Acting Injection and Patch Technologies

Daewoong Pharmaceutical is pursuing global opportunities with three next-generation drug delivery platforms designed for long-acting injections, microneedle patches and highly concentrated biologic formulations.

PRBom and MSD Korea Place Third in Global PR Awards for HPV Prevention Campaign

A decade-long campaign by PRBom and MSD Korea to raise awareness of HPV prevention has placed third in the 2026 Global SABRE Awards, standing out as the only South Korean campaign among the 40 finalists.

Celltrion Pharm Launches Prefilled-Syringe Version of Yuflyma in South Korea, Strengthening Price Competitiveness

Celltrion Pharm has launched a safety-equipped prefilled-syringe version of its Humira biosimilar Yuflyma in South Korea, expanding treatment options while offering one of the lowest prices among products containing the same active ingredient.

Konkuk University Medical Team Surpasses 6,000 Microvascular Decompression Surgeries

A neurosurgery team at Konkuk University Medical Center has performed more than 6,000 microvascular decompression procedures to treat hemifacial spasm and trigeminal neuralgia, a milestone achieved by few medical teams worldwide.
Latest

Revolutionizing Regenerative Medicine: How Noul’s AI Blood Analysis is Transforming Stem Cell Treatments

Noul partners with Infinite Medical to enhance its AI blood analysis tool, miLab™ BCM, for stem cell regenerative therapies.

Samjin Pharmaceutical and Ewha Womans University Seoul Hospital Sign MOU for Innovative Migraine Treatment

Samjin Pharmaceutical partners with Ewha Womans University Medical Center to develop treatments for CNS disorders, focusing on migraines.

Lunit’s 200 Billion KRW Funding: How Atinum Investment Boosts AI in Healthcare

Lunit secures 30 billion KRW investment from Atinum to enhance global R&D and operations, reinforcing its position in medical AI.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

ST Pharm secures a patent in Japan for its mRNA delivery technology, enhancing its global market position and IP portfolio.

How is Omlyclo Revolutionizing Allergy Treatment in Europe: Key Successes and Insights

Celltrion's Omlyclo treatment is rapidly gaining market share in Europe, winning tenders and expanding prescriptions across multiple countries.

Wontec’s Bold Move: 6 Billion KRW Buyback to Boost Shareholder Value in 2026

Wontech plans to repurchase shares worth 6 billion KRW to boost shareholder value and confidence, aiming for strong growth by 2025.

24-Hour Emergency Hotline: How GC’s New Service Supports Koreans in Vietnam

GC has partnered to launch a 24-hour emergency hotline for Koreans in Hanoi, enhancing access to medical services and support.

HLB Life Science R&D: Leading the Charge in CBD Pharmaceutical Development in 2026

HLB Life Science R&D partners for a national project to develop medical cannabis-based pharmaceuticals, focusing on CBD production.

Daewoong Pharmaceutical Expands Indication for Fexuclue: What This Means for 2026

Daewoong Pharmaceutical submits Phase 3 trial plan for Fexuclue to treat gastric ulcers, aiming to enhance treatment options and patient quality of life.

AI-Designed Proteins: How KAIST’s Breakthrough Could Revolutionize Disease Diagnosis and Drug Development

KAIST's Professor Lee Kyu Ri has designed AI-based artificial proteins for specific compound recognition, enabling advanced biosensors.

How 144 Key Genes Could Revolutionize Cardiomyopathy Treatment: Insights from Recent Study

Researchers identified 144 key genes linked to cardiomyopathy, suggesting complex interactions among cell types may drive the condition.

Revolutionary Male Contraceptive: New Method Halts Sperm Production Without Hormonal Side Effects

A Cornell team developed a reversible male contraceptive, blocking sperm production without hormonal side effects, using a compound called JQ1.

AACR 2026: How Korean Biotech Firms Are Leading the Charge in Cancer Research

AACR 2026 in San Diego will showcase South Korea's cancer tech innovations, featuring firms like Hanmi and Samsung Biologics.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.